Literature DB >> 3029716

Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice.

R N Sifers, J A Carlson, S M Clift, F J DeMayo, D W Bullock, S L Woo.   

Abstract

Normal and mutant human alpha-1-antitrypsin genes were cloned from a PiMZ heterozygous individual. Nucleotide sequence comparison demonstrated a T to C transition in exon III and an G to A transition in exon V of the PiZ gene. A 14.4 kb DNA fragment containing the entire PiM gene plus 2 kb of 5' and 3' flanking genomic DNA sequences was introduced into the germ line of mice and five F0 transgenic lines were established. Transgenic F1 progeny from F0 parents exhibited high levels of human alpha-1-antitrypsin protein in their plasma. The human gene was expressed primarily in liver of the transgenic mice as it is in man. However, expression of the human alpha-1-antitrypsin gene was also observed in kidneys of the transgenic mice, which led to the observation that the endogenous mouse gene is also expressed in the kidney. These data indicate that cis-acting elements within or proximal to the human alpha-1-antitrypsin gene are able to direct its in vivo transcription with a high degree of tissue specificity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029716      PMCID: PMC340561          DOI: 10.1093/nar/15.4.1459

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  42 in total

1.  Molecular abnormality of human alpha1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency.

Authors:  A Yoshida; J Lieberman; L Gaidulis; C Ewing
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

2.  PULMONARY EMPHYSEMA AND ALPHA1-ANTITRYPSIN DEFICIENCY.

Authors:  S ERIKSSON
Journal:  Acta Med Scand       Date:  1964-02

3.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Restriction enzyme MaeIII for prenatal diagnosis of alpha 1-antitrypsin deficiency.

Authors:  D W Cox; G D Billingsley
Journal:  Lancet       Date:  1986-09-27       Impact factor: 79.321

6.  Purification and partial characterization of pas-positive inclusion bodies from the liver in alpha 1-antitrypsin deficiency.

Authors:  S Eriksson; C Larsson
Journal:  N Engl J Med       Date:  1975-01-23       Impact factor: 91.245

7.  A new method for determination of alpha-1-antitrypsin phenotypes using isoelectric focusing on polyacrylamide gel slabs.

Authors:  R C Allen; R A Harley; R C Talamo
Journal:  Am J Clin Pathol       Date:  1974-12       Impact factor: 2.493

8.  Molecular structure and polymorphic map of the human phenylalanine hydroxylase gene.

Authors:  A G DiLella; S C Kwok; F D Ledley; J Marvit; S L Woo
Journal:  Biochemistry       Date:  1986-02-25       Impact factor: 3.162

9.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

10.  Alpha-1-antitrypsin content in the serum, alveolar macrophages, and alveolar lavage fluid of smoking and nonsmoking normal subjects.

Authors:  G N Olsen; J O Harris; J R Castle; R H Waldman; H J Karmgard
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

View more
  34 in total

1.  Chromosomal elements regulate gene activity and chromatin structure of the human serpin gene cluster at 14q32.1.

Authors:  Mark D Marsden; R E K Fournier
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

2.  Tissue-specific expression of the human alpha 1-antitrypsin gene is controlled by multiple cis-regulatory elements.

Authors:  R F Shen; Y Li; R N Sifers; H Wang; C Hardick; S Y Tsai; S L Woo
Journal:  Nucleic Acids Res       Date:  1987-10-26       Impact factor: 16.971

3.  Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice.

Authors:  J A Carlson; B B Rogers; R N Sifers; M J Finegold; S M Clift; F J DeMayo; D W Bullock; S L Woo
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

4.  Molecular basis for defective secretion of the Z variant of human alpha-1-proteinase inhibitor: secretion of variants having altered potential for salt bridge formation between amino acids 290 and 342.

Authors:  A A McCracken; K B Kruse; J L Brown
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

5.  Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver.

Authors:  M Véniant; J Ménard; P Bruneval; S Morley; M F Gonzales; J Mullins
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

6.  Multiple tissues express alpha 1-antitrypsin in transgenic mice and man.

Authors:  J A Carlson; B B Rogers; R N Sifers; H K Hawkins; M J Finegold; S L Woo
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

7.  Multiple hepatic trans-acting factors are required for in vitro transcription of the human alpha-1-antitrypsin gene.

Authors:  Y Li; R F Shen; S Y Tsai; S L Woo
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

8.  The cytoplasmic tail of human mannosidase Man1b1 contributes to catalysis-independent quality control of misfolded alpha1-antitrypsin.

Authors:  Ashlee H Sun; John R Collette; Richard N Sifers
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

Review 9.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

Review 10.  Utilization of transgenic mice in the study of matrix degrading proteinases and their inhibitors.

Authors:  R Khokha; D C Martin; J E Fata
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.